Preclinical study finds insomnia drug blocks oxycodone relapse
The insomnia drug suvorexant (Belsomra) might be an effective treatment for opioid use disorder, according to a preclinical study from Scripps Research.
Apr 27, 2023
0
36
The insomnia drug suvorexant (Belsomra) might be an effective treatment for opioid use disorder, according to a preclinical study from Scripps Research.
Apr 27, 2023
0
36
To everything there is a season, and for the flu, it's wintertime. Flu cases peak between December and February, and the flu vaccine is your best defense. Getting the vaccine means you will be less sick even if you get a ...
Feb 7, 2023
0
9
Cancer patients are commonly treated with the maximum dose they are able to withstand that does not cause too many toxic side effects. However, many patients become resistant to these treatments and develop cancer recurrence. ...
Apr 30, 2018
0
9
A phase I clinical trial showed diffuse, large B-cell lymphomas (DLBCLs) resistant to chemotherapy can be reprogrammed to respond to treatment using the drug azacitidine, according to a study published in Cancer Discovery, ...
Aug 16, 2013
0
0
Syria's opposition said Thursday that 16 children who died during a measles vaccination campaign in the mostly rebel-held province of Idlib had been given an anaesthesia additive by mistake.
Sep 18, 2014
0
0
Protecting the stem cells that reside in and around the hippocampus – a C-shaped area in the temporal lobe on both sides of the brain associated with the ability to form and store memories – substantially reduces the ...
Sep 23, 2013
0
0
External beam radiation treatment has long been manipulated into the unique shape of patients' tumors for personalized cancer care. Technology providing a means of patient-specific radionuclide drug therapies has not been ...
Jun 11, 2013
0
0
Researchers have shown for the first time that it is possible to reduce the distressing symptoms of dry mouth in patients treated with radiotherapy for head and neck cancers if the radiation dose to a salivary gland (called ...
Apr 20, 2013
0
0
The nanoparticle drug BIND-014 is effective against multiple solid tumors, according to results generated by the Translational Genomics Research Institute (TGen) and Scottsdale Healthcare, and presented today at the American ...
Apr 9, 2013
0
0
In a study to be presented on February 14 at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in San Francisco, California, researchers will present data showing racial and ethnic disparities ...
Feb 11, 2013
0
0